VGN-R09b

DRUG2 trials

Sponsors

Shanghai Jiao Tong University School of Medicine, Shanghai Vitalgen BioPharma Co., Ltd.

Conditions

Aromatic L-amino Acid Decarboxylase (AADC) DeficiencyParkinson's Disease

Early Phase 1

An Early Clinical Trial to Evaluate VGN-R09b for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency.

RecruitingNCT05765981

Shanghai Jiao Tong University School of MedicineAromatic L-amino Acid Decarboxylase (AADC) Deficiency

Start: 2023-01-30End: 2029-02-20Target: 6Updated: 2023-03-13

Phase 1

A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease

Active, not recruitingNCT06480461

Shanghai Vitalgen BioPharma Co., Ltd.Parkinson's Disease

Start: 2024-09-02End: 2030-09-10Target: 39Updated: 2026-03-31